GSK's Blenrep (belantamab mafodotin) has officially been approved by the UK's Medicines and Healthcare products Regulatory Agency (MHRA), its first approval in the world for the multiple myeloma drug ...

In December, 2021, all 194 Member States of WHO decided to establish the Intergovernmental Negotiating Body (INB) to draft and negotiate a convention, agreement, or other international instrument on ...

According to DelveInsight's analysis, the market for GIST is anticipated to increase during the forecast period (2025–2034), owing to the launch of e ...

Growth Drivers include demand for protein-based drugs, rise in chronic disease prevalence, precision medicine expansion, biotech advancements, and AI-driven design tools.Dublin, April 14, 2025 (GLOBE ...

GSK plc (LSE/NYSE: GSK) today announced the recipients of its COiMMUNITY Initiative grant program, awarding nearly $2 million to 15 regional, state and national non-profits and community-based groups ...

NEW YORK, NY / ACCESS Newswire / April 7, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential ...

The IQVIA Institute for Human Data Science has released, Global Trends in R&D 2025 report, Progress in Recapturing Momentum ...

The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the ...

GSK has continued to flesh out its neuroscience strategy with a 2 billion pound sterling ($2.5 billion) deal to use a South Korean company’s tech to bypass the blood-brain barrier. ABL Bio has ...

Pharma firm GSK has been accused of burying a report said to prove a link between its medication Zantac and cancer, a new ...

("GSK" or the "Company") (NYSE: GSK) American Depositary Receipts ("ADRs") between February 5, 2020, and August 14 ... the Deutsche Bank report stated that the total liability could be between $5 ...

Wall Street suffers its worst day since 2020 but the White House tells investors to "trust in President Trump".